Skip to content

Genvinset® HLA Narcolepsy 24 tests

by Blackhills Diagnostic Resources S.L.U. EUDAMED

Active European Union

Ref GVS-NP-24Model Genvinset® HLA Narcolepsy

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number8437016942GVS-NPF7 Basic UDI-DIDate30 Oct 2023RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED

Device Name
Genvinset® HLA Narcolepsy
Model / Reference
Genvinset® HLA Narcolepsy, GVS-NP-24
Primary DI / UDI-DI
08437016942154
Basic UDI-DI
8437016942GVS-NPF7
EMDN Code
W0106010401 Hla-typing
Device Class
Class C
Market of Registration
Spain

Manufacturer details

EUDAMED SRN
ES-MF-000001091

Other devices from Blackhills Diagnostic Resources S.L.U.

See all devices from Blackhills Diagnostic Resources S.L.U. →

Properties

Show properties
  • Microbial Substances
  • Reagent
  • Professional Testing
Other properties (8)
  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No